Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System
Go back to Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 116.76 -1.29 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $118.05 | 52 Week High | $118.49 | |||
| Open | $118.06 | 52 Week Low | $55.00 | |||
| Day High | $118.77 | P/E | N/A | |||
| Day Low | $116.46 | EPS | $-0.56 | |||
| Volume | 714,969 | |||||
